Eureka AIR delivers breakthrough ideas for toughest innovation challenges, trusted by R&D personnel around the world.

Down's syndrome risk assessment method for prenatal screening in pregnant metaphase

A technology for Down syndrome and risk estimation, which is applied in the field of Down syndrome risk calculation in prenatal screening in the second trimester, can solve problems such as deviation of test results, reduce false positive rate, improve screening efficiency, and improve screening efficiency. high effect

Inactive Publication Date: 2015-11-18
NINGBO UNIV
View PDF0 Cites 8 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0003] At present, the methods and software used in China's prenatal screening are all software developed abroad. Most of the models used in the software are risk estimation methods established by foreign experts in the 1980s, using a multivariate normal model. The data distribution of each variable is required to be a normal distribution, and there are many restrictions when using it. The principle of these methods and software is to collect data from foreign normal and diseased populations (such as North Caucasians), and establish a judgment model. Domestic normal pregnant women The values ​​of serological indicators in the population are significantly different from those of normal pregnant women abroad, resulting in deviations in test results

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Down's syndrome risk assessment method for prenatal screening in pregnant metaphase
  • Down's syndrome risk assessment method for prenatal screening in pregnant metaphase
  • Down's syndrome risk assessment method for prenatal screening in pregnant metaphase

Examples

Experimental program
Comparison scheme
Effect test

Embodiment Construction

[0036] Below in conjunction with embodiment the present invention is described in further detail.

[0037] From April 2007 to April 2012 in Ningbo, 66,874 screening samples were collected from all pregnant women under the age of 35, with a gestational age of 15-20 gestational weeks (105-140 days), and a body weight of 35-110 kg. The risk estimation formula for Down's syndrome in the prenatal screening in the second trimester of the present invention is compared with the existing foreign prenatal screening software.

[0038] (1) Data collection: collect the serum marker test results, body weight, menstrual cycle, and last menstrual period of pregnant women aged 18-35, gestational age at 15-20 gestational weeks (105-140 days), and body weight 35-110kg Time, pregnancy results, ultrasonic biparietal diameter and ultrasonic crown-hip distance detection results, ultrasonic detection time and blood collection time;

[0039] (2) Determining the gestational age based on gestational da...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The present invention discloses a Down's syndrome risk assessment method for prenatal screening in pregnant metaphase, which includes the following steps: 1) collecting serological index testing results of pregnant women who meet the requirement of age, gestation age and weight; 2) determining gestation ages; 3) determining a median of a serological index of normal pregnant women of each of pregnancy days to obtain a regression formula of the median of the serological index of the normal pregnant women of each of pregnancy days relative to pregnancy days; 4) determining a multiple of the median of the tested pregnant women; 5) adjusting the multiple of the median of the tested pregnant women by the regression formula; 6) establishing a coefficient of a risk assessment formula of Down's syndrome by Logistic regression; 7) establishing the risk assessment formula of a triple test scheme and a double test scheme of Down's syndrome. The method based on pregnancy days and applied to prenatal screening aims at Chinese pregnant women, and has high positive rate and low false positive.

Description

technical field [0001] The invention relates to a method for calculating the risk of Down's syndrome in prenatal screening in the second trimester, belonging to the field of medical clinical diagnosis. Background technique [0002] There are 1 million birth defects in China every year, and only 30% of them can be cured or corrected. Since the incidence of birth defects is very stable and there is no effective treatment, the key to reducing birth defects lies in prevention and prenatal screening. and diagnosis. [0003] At present, the methods and software used in China's prenatal screening are all software developed abroad. Most of the models used in the software are risk estimation methods established by foreign experts in the 1980s, using a multivariate normal model. The data distribution of each variable is required to be a normal distribution, and there are many restrictions when using it. The principle of these methods and software is to collect data from foreign norma...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): G06F19/00
Inventor 卓仁杰沈其君张莉娜
Owner NINGBO UNIV
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Eureka Blog
Learn More
PatSnap group products